Xiao Jun Huang - Concepedia

Author

Xiao Jun Huang

Peking University People's Hospital ORCID

Also Known As

Xiao Huang, Xiao J. Huang, Xiao Jun Huang, Xiao jun Huang, Xiao-Jun Huang

108

Publications

549

Citations

H-Index

Concepts

All Affiliations

Peking University People's Hospital Peking University Anhui Medical University Fujian Medical University Sun Yat-sen University

About

Xiao Jun Huang is an author at Peking University People's Hospital specializing in medicine, immunology, and glomerular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	317
2	Immunology	2	2	317
3	Pathology	1	1	16
4	Autoimmunity	1	1	301
5	Genetic Epidemiology	1	1	301

Xiao Jun Huang

Publications

433

Citations

H-Index

Page 1

	Year	Citations
A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy Xue Qing Yu, Ming Li, Hong Zhang, Nature Genetics Glomerular DiseaseGlomerulonephritisDisease SusceptibilityGenome-wide Association StudyLupus	2011	301
Minimal residual disease status predicts outcome of acute myeloid leukaemia patients undergoing T‐cell replete haploidentical transplantation. An analysis from the Acute Leukaemia Working Party (<scp>ALWP</scp>) of the European Society for Blood and Marrow Transplantation (<scp>EBMT</scp>) Jonathan Canaani, Myriam Labopin, Xiao Jun Huang, British Journal of Haematology	2018	33
Phenotypic Modulation of Corpus Cavernosum Smooth Muscle Cells in a Rat Model of Cavernous Neurectomy Fan Yang, Jian F. Zhao, Qi Y. Shou, PLoS ONE	2014	28
Prognostic power of abnormal cytogenetics for multiple myeloma: a multicenter study in China. Yue Yun Lai, Xiao Jun Huang, Zhen Cai, PubMed	2012	23
Morphology and morphogenesis of severe acute respiratory syndrome (SARS)-associated virus. Qin Fen Zhang, Jin Ming Cui, Xiao Jun Huang, PubMed New VirusVirus StructureDiagnostic VirologyViral EvolutionViral Diagnostics	2003	16
Terminal differentiation and persistence of effector regulatory T cells essential for preventing intestinal inflammation Stanislav Dikiy, Aazam P. Ghelani, Andrew G. Levine, Nature Immunology	2025	12
Imatinib Mesylate Resistance in a Chronic Myeloid Leukemia Patient with a Novel e8a2 BCR-ABL Transcript Variant Ya Zhen Qin, Bin Jiang, Qian Jiang, Acta Haematologica	2008	10
Safety and Efficacy of HQP1351, a 3rd Generation Oral BCR-ABL Inhibitor in Patients with Tyrosine Kinase Inhibitor—Resistant Chronic Myelogenous Leukemia: Preliminary Results of Phase I Study Qian Jiang, Xiao Jun Huang, Zi Chen, Blood	2018	10

Page 1